A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200

NCT01564225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Hypohidrotic Ectodermal Dysplasia

Interventions

DRUG: EDI200

Sponsor

Edimer Pharmaceuticals